245 related articles for article (PubMed ID: 33510271)
1. A clinical pilot study on the effect of the probiotic Lacticaseibacillus rhamnosus TOM 22.8 strain in women with vaginal dysbiosis.
Pino A; Rapisarda AMC; Vitale SG; Cianci S; Caggia C; Randazzo CL; Cianci A
Sci Rep; 2021 Jan; 11(1):2592. PubMed ID: 33510271
[TBL] [Abstract][Full Text] [Related]
2. Lacticaseibacillus rhamnosus TOM 22.8 (DSM 33500) is an effective strategy for managing vaginal dysbiosis, rising the lactobacilli population.
Vaccalluzzo A; Pino A; Grimaldi RL; Caggia C; Cianci S; Randazzo CL
J Appl Microbiol; 2024 May; 135(5):. PubMed ID: 38755019
[TBL] [Abstract][Full Text] [Related]
3.
Pino A; Vaccalluzzo A; Caggia C; Balzaretti S; Vanella L; Sorrenti V; Ronkainen A; Satokari R; Randazzo CL
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432588
[TBL] [Abstract][Full Text] [Related]
4. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.
Recine N; Palma E; Domenici L; Giorgini M; Imperiale L; Sassu C; Musella A; Marchetti C; Muzii L; Benedetti Panici P
Arch Gynecol Obstet; 2016 Jan; 293(1):101-107. PubMed ID: 26142892
[TBL] [Abstract][Full Text] [Related]
5. Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection.
Palma E; Recine N; Domenici L; Giorgini M; Pierangeli A; Panici PB
BMC Infect Dis; 2018 Jan; 18(1):13. PubMed ID: 29304768
[TBL] [Abstract][Full Text] [Related]
6. Effect of Oral Probiotic
Yang S; Reid G; Challis JRG; Gloor GB; Asztalos E; Money D; Seney S; Bocking AD
Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019222
[TBL] [Abstract][Full Text] [Related]
7. [Effect of Lactobacillus casei var rhamnosus (Gynophilus) in restoring the vaginal flora by female patients with bacterial vaginosis--randomized, open clinical trial].
Kovachev S; Dobrevski-Vacheva R
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():48-53. PubMed ID: 24294746
[TBL] [Abstract][Full Text] [Related]
8. [Probiotic monotherapy of bacterial vaginosis: a open, randomized trial].
Kovachev S; Dobrevski-Vacheva R
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():36-42. PubMed ID: 24294744
[TBL] [Abstract][Full Text] [Related]
9. Dysbiosis of the rat vagina is efficiently rescued by vaginal microbiota transplantation or probiotic combination.
Chen T; Xia C; Hu H; Wang H; Tan B; Tian P; Zhao X; Wang L; Han Y; Deng KY; Wei H; Xin HB
Int J Antimicrob Agents; 2021 Mar; 57(3):106277. PubMed ID: 33434677
[TBL] [Abstract][Full Text] [Related]
10. Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs.
van de Wijgert J; Verwijs MC
BJOG; 2020 Jan; 127(2):287-299. PubMed ID: 31299136
[TBL] [Abstract][Full Text] [Related]
11. Probiotic Lactobacilli for urogenital health in women.
Reid G
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S234-6. PubMed ID: 18685506
[TBL] [Abstract][Full Text] [Related]
12. Vaginal Microbiota.
Mendling W
Adv Exp Med Biol; 2016; 902():83-93. PubMed ID: 27161352
[TBL] [Abstract][Full Text] [Related]
13. Adhesion of human probiotic Lactobacillus rhamnosus to cervical and vaginal cells and interaction with vaginosis-associated pathogens.
Coudeyras S; Jugie G; Vermerie M; Forestier C
Infect Dis Obstet Gynecol; 2008; 2008():549640. PubMed ID: 19190778
[TBL] [Abstract][Full Text] [Related]
14. [SLOW RELEASED LOCAL PROBIOTICS].
Kovachev S; Ganovska A; Stoyanova M
Akush Ginekol (Sofiia); 2015; 54 Suppl 2():18-22. PubMed ID: 26817248
[TBL] [Abstract][Full Text] [Related]
15. Probiotics for the treatment of women with bacterial vaginosis.
Falagas M; Betsi GI; Athanasiou S
Clin Microbiol Infect; 2007 Jul; 13(7):657-64. PubMed ID: 17633390
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.
Vicariotto F; Mogna L; Del Piano M
J Clin Gastroenterol; 2014; 48 Suppl 1():S106-12. PubMed ID: 25291116
[TBL] [Abstract][Full Text] [Related]
17. A systems biology approach investigating the effect of probiotics on the vaginal microbiome and host responses in a double blind, placebo-controlled clinical trial of post-menopausal women.
Bisanz JE; Seney S; McMillan A; Vongsa R; Koenig D; Wong L; Dvoracek B; Gloor GB; Sumarah M; Ford B; Herman D; Burton JP; Reid G
PLoS One; 2014; 9(8):e104511. PubMed ID: 25127240
[TBL] [Abstract][Full Text] [Related]
18. Characterization and complete genome sequences of L. rhamnosus DSM 14870 and L. gasseri DSM 14869 contained in the EcoVag
Marcotte H; Krogh Andersen K; Lin Y; Zuo F; Zeng Z; Larsson PG; Brandsborg E; Brønstad G; Hammarström L
Microbiol Res; 2017 Dec; 205():88-98. PubMed ID: 28942850
[TBL] [Abstract][Full Text] [Related]
19. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
BMC Infect Dis; 2019 Sep; 19(1):824. PubMed ID: 31533663
[TBL] [Abstract][Full Text] [Related]
20. The role of lactic acid production by probiotic Lactobacillus species in vaginal health.
Tachedjian G; Aldunate M; Bradshaw CS; Cone RA
Res Microbiol; 2017; 168(9-10):782-792. PubMed ID: 28435139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
